BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 38664521)

  • 1. Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.
    Cao L; Liu M; Ma X; Rong P; Zhang J; Wang W
    Curr Med Chem; 2024; 31(17):2414-2430. PubMed ID: 37936457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prognostic model for predicting patient survival and immunotherapy responsiveness in hepatocellular carcinoma: insights into the involvement of T-cell proliferation.
    Tang S; Sun R; Tang K; Wei X; Liu M; Zhang H
    Clin Transl Oncol; 2024 Jun; 26(6):1368-1383. PubMed ID: 38123874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis/disulifidptosis-related gene SLC7A11 predicts prognosis, immune infiltration, and immunotherapy response in hepatocellular carcinoma.
    Pan Y; Zhang Y; Zhu G; Li S
    Asian J Surg; 2024 Jun; 47(6):2726-2728. PubMed ID: 38531741
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma.
    Gao X; Ren X; Wang F; Ren X; Liu M; Cui G; Liu X
    Sci Rep; 2024 Apr; 14(1):9509. PubMed ID: 38664521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma.
    Zhang S; Guo H; Wang H; Liu X; Wang M; Liu X; Fan Y; Tan K
    Apoptosis; 2024 Jun; 29(5-6):768-784. PubMed ID: 38493408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sorafenib resistance-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Luo T; Chen X; Pan W; Zhang S; Huang J
    Cell Cycle; 2024 Jan; 23(2):150-168. PubMed ID: 38444181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
    Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
    Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis.
    Liu X; Li X; Wei H; Liu Y; Li N
    Front Immunol; 2023; 14():1209056. PubMed ID: 37497234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated PTTG1 switches its subcellular distribution and promotes β-catenin stabilization and subsequent transcription activity.
    Zhang X; Wu N; Huang H; Li S; Liu S; Zhang R; Huang Y; Lyu H; Xiao S; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
    Oncogene; 2023 Aug; 42(32):2439-2455. PubMed ID: 37400529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.